Oscar Robinson

Since joining Kirkland, Oscar has been involved in the following matters:

• Acting for a multinational telecommunications company in its defence of a global FRAND licensing action.
• Acting for leading biopharmaceutical company in ongoing damages proceedings.

Prior to joining Kirkland, Oscar worked on the following matters:

• Acted for another multinational telecommunications company in defending a market-leading global FRAND and SEP infringement action, including a jurisdictional challenge to the UK Supreme Court made against the English Court’s ability to grant global FRAND licences.
• Premaitha Health v Illumina — Represented Premaitha Health, a small UK-based innovative diagnostics company, in a large, multi-patent litigation relating to non-invasive prenatal testing and next generation sequencing technology against Illumina, Inc.
• Warner-Lambert v Actavis; Warner-Lambert v Mylan — Represented Warner-Lambert (a Pfizer group company) in relation to landmark UK second medical use patent litigation against multiple generic parties concerning Lyrica® (pregabalin), its multi-billion dollar blockbuster treatment for pain. The case is considered to be seminal authority on a wide range of previously unresolved legal issues in relation to the validity and enforcement of second medical use patents in the UK.
• Teva v Boehringer Ingelheim — Acted for Boehringer Ingelheim in its global formulation patent against Teva in relation to BI’s blockbuster SPIRIVA® COPD inhalation product worth over $3 billion in sales worldwide.
• Warner-Lambert v Sandoz — Represented Warner-Lambert (a Pfizer group company) in successfully securing urgent injunctive relief to prevent the launch of a full label generic version of Lyrica® (pregabalin), its multi-billion dollar blockbuster treatment for pain.
• Acted for a global pharmaceutical company on worldwide product lifecycle management strategy for a key neurology product. 

Allen & Overy LLP, London

• Associate (2016–2021)
• Trainee Solicitor (2014–2016)